Evidence map›Paper›PMID 21068255›Full record

ArticleJournal of virology2011

Role for ADP ribosylation factor 1 in the regulation of hepatitis C virus replication.

Meirav Matto, Ella H Sklan, Naama David, Naomi Melamed-Book, James E Casanova, Jeffrey S Glenn, Benjamin Aroeti

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Kinesin-dependent mechanism for controlling triglyceride secretion from the liver.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  10. Article
  11. Hepatitis C virus triggers Golgi fragmentation and autophagy through the immunity-related GTPase M.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  12. Article
  13. Article
  14. A role for retromer in hepatitis C virus replication.Cellular and molecular life sciences : CMLS · 2016
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Meirav MattoDepartment of Cell and Developmental Biology, Institute of Life Sciences, Hebrew University of Jerusalem, Jerusalem 91904, Israel.
Ella H Sklan
Naama David
Naomi Melamed-Book
James E Casanova
Jeffrey S Glenn
Benjamin Aroeti
Hebrew University of Jerusalem · ILTel Aviv University · ILInstitute of Life Sciences · INStanford University · USUniversity of Virginia Health System · US

Funding

UVA Digestive Health Research CenterP30DK067629 · NIDDK · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI COMINELLI, FABIO · 2004 to 2008
$5.6M
NIDDK NIH HHS P30 DK067629
6 · The paper itself

Abstract

We hypothesized that ADP-ribosylation factor 1 (Arf1) plays an important role in the biogenesis and maintenance of infectious hepatitis C virus (HCV). Huh7.5 cells, in which HCV replicates and produces infectious viral particles, were exposed to brefeldin A or golgicide A, pharmacological inhibitors of Arf1 activation. Treatment with these agents caused a reduction in viral RNA levels, the accumulation of infectious particles within the cells, and a reduction in the levels of these particles in the extracellular medium. Fluorescence analyses showed that the viral nonstructural (NS) proteins NS5A and NS3, but not the viral structural protein core, shifted their localization from speckle-like structures in untreated cells to the rims of lipid droplets (LDs) in treated cells. Using pulldown assays, we showed that ectopic overexpression of NS5A in Huh7 cells reduces the levels of GTP-Arf1. Downregulation of Arf1 expression by small interfering RNA (siRNA) decreased both the levels of HCV RNA and the production of infectious viral particles and altered the localization of NS5A to the peripheries of LDs. Together, our data provide novel insights into the role of Arf1 in the regulation of viral RNA replication and the production of infectious HCV.

Indexed as

Virus ReplicationADP-Ribosylation Factor 1Brefeldin ACell LineDEAD-box RNA HelicasesEnzyme InhibitorsGene Knockdown TechniquesHepacivirusHepatocytesHumansNucleoside-TriphosphatasePyridinesQuinolinesRNA-Dependent RNA PolymeraseRNA, Small InterferingSerine EndopeptidasesADP-Ribosylation Factor 1Brefeldin ADEAD-box RNA HelicasesEnzyme Inhibitorsgolgicide ANS3 protein, hepatitis C virusNS-5 protein, hepatitis C virusNucleoside-TriphosphatasePyridinesQuinolinesRNA-Dependent RNA PolymeraseRNA, Small InterferingSerine EndopeptidasesViral Nonstructural ProteinsViral Proteases

Identifiers

PMID21068255
PMCPMC3020004
OpenAlexW2143842613

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.